Reach Us +44-1477412632
Hair Therapy and Transplantation- Open Access Journals
ISSN: 2167-0951

Hair Therapy & Transplantation
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Editorial Board
Editor Image

Mohamed Lotfy Elsaie
Department of Dermatology and Cutaneous Surgery
University of Miami School of Medicine

Editor Image

Shigeki Inui

Associate Professor
Department of Regenerative Dermatology
Osaka University Graduate School of Medicine

Editor Image

Xiaowei Xu
Professor of Pathology and Dermatology
University of Pennsylvania
Dept. of Pathology and Laboratory Medicine
Philadelphia, USA

Editor Image

Nooshin Bagherani
Independent researcher, Dermatologist at Dr. Nooshin Bagherani’s Office,
Khoramshahr, Iran

Submit Manuscript

Journal Impact Factor 0.608*
Submit manuscript at or send as an e-mail attachment to the Editorial Office at [email protected]

About the Journal

Index Copernicus Value: 62.78 

Hair Therapy and Transplantation is a medical and surgical process adapted to minimize hair loss and to promote hair growth.

Hair Therapy and Transplantation is a peer reviewed medical journal that includes a wide range of fields in its discipline to create a platform for the authors to make their contribution towards the journal and the editorial office promises peer reviewing of the submitted manuscripts for the quality of publishing.
Hair Therapy and Transplantation is one of the best open access journal that aims to publish the most complete and reliable source of information on discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in the field and provide free access through online without any restrictions or any other subscriptions to researchers worldwide.
This top best scholarly journal is using Editorial Manager® System for quality in online manuscript submission, review and tracking system. Editorial board members of Hair: Therapy and Transplantation Journal or outside experts complete the review: at least two independent reviewer’s approval followed by the editor is required for the acceptance of any citable manuscript.
OMICS International organizes 300+ conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and publishes 400+ scholarly open access journals which contain over 30000 eminent personalities, reputed scientists as editorial board members. Submit manuscript at or send as an e-mail attachment to the Editorial Office at [email protected]  
Aims and Scope

Congenital Alopecia

Congenital alopecia is the loss of hair, complete and absolute. More commonly it consists of alopecia, with scanty, incompletely grown, or lanugo-like hair. It is commonly associated with other defects like dental aplasias. In a few instances it was found in association with anomalies in the sweat glands, impaired senses of taste and smell and epidermolysis bullosa.

Alopecia as an outcome of chemotherapy for a malignancy can be very distressing. The loss of hair usually is temporary and the hair will grow back after the course of treatment is completed. Male patients may feel more comfortable wearing a hat or cap when out in public. Female patients who wish to wear a wig are encouraged to obtain one that is lightweight and the same color as their hair.

Related Journals of Congenital Alopecia

Dermatitis Journal, Clinical and Experimental Dermatology,  International Journal of Trichology, American Journal of Clinical Dermatology, Annals of Dermatology, Australasian Journal of Dermatology, BMC Dermatology, British Journal of Dermatology, Case Reports in Dermatology, Clinical, Cosmetic and Investigational Dermatology


Corticosteroids are man-made drugs that closely resemble cortisol, a hormone that adrenal glands produce naturally. Corticosteroids are different from the male hormone-related steroid compounds that some athletes abuse. It is class of chemicals that includes the steroid hormones produced in the adrenal cortex of vertebrates as well as the synthetic analogues.

Corticosteroids are a class of chemical substances that include steroid hormones that are produced in the adrenal cortex of vertebrates as well as the synthetic analogues of these hormones. Corticosteroids are involved in a wide range of physiological processes, including stress response, immune response, regulation of inflammation, carbohydrate metabolism, protein catabolism, blood electrolyte levels, and behavior. E.g: Corticosterone, Cortisone, Aldosterone.

Related Journals of Corticosteroids

Steroids, Vitamins and Hormones, Hormones and Behavior, Hormones (Athens, Greece)

Female Pattern Hair Loss

Female Pattern Hair Loss (FPHL) occurs in approximately 50% of women by the age of 50 years old. Although it starts with increased shedding, over time the hair loss is characterized primarily by a decrease in hair density over the top of the scalp. Affected women note a decrease in the size of their hair.

Female pattern baldness involves a typical pattern of hair loss in women, due to hormones, aging, and genes. FPHL has a strong genetic predisposition. The mode of inheritance is polygenic, indicating that there are many genes that contribute to FPHL, and these genes could be inherited from either parent, or both. Genetic testing to assess risk of balding is currently not recommended, as it is unreliable. The majority of women with FPHL have normal levels of androgens in their bloodstream.

Related Journals of Female Pattern Hair Loss

British Journal of DermatologyInternational Journal of Trichology, Australasian Journal of Dermatology,BMC Dermatology, Case Reports in Dermatology, Clinical and Experimental Dermatology, Clinical, Cosmetic and Investigational Dermatology

Frontal Fibrosing Alopecia

Frontal fibrosing alopecia (FFA) is a primary lymphocytic cicatricial alopecia with a distinctive clinical pattern of hair loss characterized by progressive recession of the frontotemporal hairline. This particular form of alopecia currently is considered a variant of lichen planopilaris because it is often accompanied by the the presence of cutaneous and/or mucous membrane lichen planus in patients.

Frontal fibrosing alopecia usually affects post-menopausal women over the age of 50. It is characterised by usually symmetrical band of hair loss on the front and sides of the scalp, and loss of eyebrows. The edge may appear moth-eaten, and single "lonely" hairs may persist in the bald areas. The skin in the affected area usually looks normal but may be pale, shiny or mildly scarred without visible follicular openings. At the margins of the bald areas, close inspection shows redness and scaling around hair follicles.

Related Journals of Frontal Fibrosing Alopecia

BMC DermatologyAmerican Journal of Clinical Dermatology, Annals of Dermatology, Australasian Journal of Dermatology, International Journal of Trichology

Hair Follicle

Hair Follicle is a sac from which a hair grows and into which the sebaceous (oil) glands open. It is lined by cells derived from the epidermal (outside) layer of the skin. Each follicle normally goes through a five-year cycle of growth, averaging about six inches (15 cm) of growth per year.

A hair follicle is a part of the skin, which grows a hair by packing old cells together. Attached inside the top of the follicle are sebaceous glands, which are tiny sebum-producing glands in almost all skin except on the palms, lips and soles of the feet. The thicker the hair, the more the number of sebaceous glandsThe average growth rate of healthy hair follicles on the scalp is nearly 0.5 inches (13 mm) per month.

Related Journals of Hair Follicle

Australasian Journal of Dermatology, Annals of Dermatology, BMC Dermatology, British Journal of Dermatology, Case Reports in Dermatology, Clinical and Experimental Dermatology, Clinical, Cosmetic and Investigational Dermatology

Hair Loss

Hair loss, or alopecia, is a concern for men, women, and children. Treatments for hair loss include medications such as Propecia and Rogaine, hair replacements, and hair restoration. It may be patchy or diffusive in manner.

Some types of hair loss can be caused by alopecia areata, an autoimmune disorder. The extreme forms of alopecia areata are alopecia totalis, which involves the loss of all head hair, and alopecia universalis, which involves the loss of all hair from the head and the body. Hair loss and hypotrichosis can have many causes, including fungal infection, traumatic damage, such as by compulsive pulling (trichotillomania), as a result of radiotherapy or chemotherapy, and as a result of nutritional deficiencies such as iron deficiency.

Related Journals of Hair Loss

Case Reports in Dermatology, Journal of Cosmotology & Laser Therapy, International Journal of Trichology, American Journal of Clinical Dermatology, Annals of Dermatology, Australasian Journal of Dermatology, BMC Dermatology, British Journal of Dermatology, Clinical and Experimental Dermatology, Clinical, Cosmetic and Investigational Dermatol

Lichen Planopilaris

Lichen planopilaris (LPP) is an uncommon inflammatory scalp disorder which is clinically characterized by perifollicular erythema, follicular hyperkeratosis, and permanent hair loss. LPP is considered a follicular form of lichen planus based upon shared pathologic features and the frequent coexistence of clinical findings of these disorders.

Lichen planopilaris typically presents as smooth white patches of scalp hair loss. No hair follicle openings can be seen in the areas of hair loss. At the edges of these patches there may be scale and redness around each hair follicle. Hairs can be easily pulled out. It is multifocal and small patches may merge to form larger irregular areas. lichen planopilaris is rare, it is one of the common causes of scarring hair loss of the scalp.

Related Journals of Lichen Planopilaris

Journal of Cosmetic Dermatology, BMC Dermatology, International Journal of Trichology, American Journal of Clinical Dermatology, Australasian Journal of Dermatology

Laser Therapy

Laser therapy is the non-invasive use of laser energy to generate a photochemical response in damaged or dysfunctional tissue. Laser therapy can alleviate pain, reduce inflammation and accelerate recovery from a wide range of acute and chronic clinical conditions. Laser therapy is a drug-free, surgery-free technique.

Laser therapy is a treatment that uses a strong beam of light to cut, burn, or destroy tissue. The term LASER stands for "Light Amplification by Stimulated Emission of Radiation." Lasers are more precise than traditional surgical instruments. Cuts can be made shorter and shallower. This causes less damage to tissue. Laser therapies are medical treatments that use focused light. Unlike most light sources, it is tuned to very specific wavelengths. This allows it to be focused into powerful beams.

Related Journals of Laser Therapy

Stem Cell Research and TherapyJournal of Cosmetic and Laser Therapy, Journal of Cosmetic Dermatology, Journal of Lasers in Medical Sciences, Lasers in Medical Science

Telogen Effluvium

Telogen effluvium is a form of non-scarring alopecia characterized by diffuse hair shedding, often with an acute onset. A chronic form with a more insidious onset and a longer duration also exists. It is a reactive process caused by a metabolic or hormonal stress or by medications.

It is a scalp disorder characterized by the thinning or shedding of hair resulting from the early entry of hair in the telogen phase (the resting phase of the hair follicle).Emotional or physiological stress may result in an alteration of the normal hair cycle and cause the disorder, with potential etiologies including eating disorders, fever, childbirth, chronic illness, major surgery, anemia, severe emotional disorders, crash diets, hypothyroidism, and drugs.

Related Journals of Telogen Effluvium

American Journal of Clinical Dermatology, Journal of Cosmetic Dermatology, International Journal of Trichology, Australasian Journal of Dermatology, BMC Dermatology


 Minoxidil is used to stimulate hair growth and to slow balding. It is most effective for people under 40 years of age. Minoxidil has no effect on receding hairlines. It does not cure baldness; generally new hair is lost within a few months if the drug is stopped.

Minoxidil is an antihypertensive vasodilator medication. It also slows or stops hair loss and promotes hair regrowth. Minoxidil is generally well tolerated, but common side effects include burning or irritation of the eye, itching, redness or irritation at the treated area, as well as unwanted hair growth elsewhere on the body. Side effects of oral minoxidil may include swelling of the face and extremities, rapid and irregular heartbeat.

Related Journals of Minoxidil

Clinical and Experimental Dermatology, Case Report in Dermatology, Journal of Cosmetic Dermatology, International Journal of Trichology, Clinical, Cosmetic and Investigational Dermatology

Mycosis Fungoides

Mycosis fungoides is the most common form of a type of cancer called cutaneous T-cell lymphoma. Cutaneous T-cell lymphomas occur when certain immune cells, called T cells, become cancerous; these cancers affect the skin, causing different types of skin lesions.

The skin cells themselves are not cancerous. Mycosis fungoides usually occurs in adults over age 50, although affected children have been identified. Mycosis fungoides progresses slowly through several stageswith the condition progress through all stages. Most affected individuals initially develop skin lesions called patches, which are flat, scaly, pink or red areas on the skin that can be itchy. Cancerous T cells, which cause the formation of patches, are found in these lesions.

Related Journals of Mycosis Fungoides

Skin Research, Skin Research and Technology, Academic Journal of Cancer Research, Advances in Cancer Research

Stem Cell Therapy

Stem cell therapy, also known as regenerative medicine, promotes the reparative response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. Stem cells have the power to go to damaged areas and regenerate new cells and tissues by performing a repair and a renewal process, restoring functionality.

Stem cell therapy which involves replenishment of the lost stem cells. Stem Cell Therapy is a ground breaking treatment for hair re-growth. The stem cells encourage new hair growth within 3 to 4 months of therapy. Unlike other hair fall treatment. The follicle of hair include stem cells in the center of the follicle and these cells make sure a constant supply of cells for the fast development of hair cells. These stem cells are gradually lost which leads to baldness

Related Journals of Stem Cell Therapy

Stem Cell ResearchCurrent Stem Cell Research and Therapy, Journal of Cosmetic and Laser Therapy, Journal of Cosmetic Dermatology, Stem Cell Research and Therapy,

Tinea Capitis

Tinea capitis is a fungal infection of the scalp. It is also called ringworm of the scalp. It is a disease caused by superficial fungal infection of the skin of the scalp, eyebrows, and eyelashes, with a propensity for attacking hair shafts and follicles.

Related Journals of Tinea Capitis

Current Fungal Infection Reports, Epidemiology and Infection, International Journal of Trichology

Trigger Point Therapy

Trigger point massage therapy is specifically designed to alleviate the source of the pain through cycles of isolated pressure and release. In this, the recipient actively participates through deep breathing as well as identifying the exact location and intensity of the discomfort.

Related Journals of Trigger Point Therapy

Molecular Diagnosis and Therapy, Journal of Transplantation Technologies and Research

Major Disease Statistics
*2018 Journal Impact Factor was established by dividing the number of articles published in 2016 and 2017 with the number of times they are cited in 2018 based on Google Scholar Citation Index database. If 'X' is the total number of articles published in 2016 and 2017, and 'Y' is the number of times these articles were cited in indexed journals during 2018 then, journal impact factor = Y/X

Recently Published Articles

Leave Your Message 24x7